PDS Biotechnology Corporation Signs Worldwide Licensing Agreement with Merck KGaA for Versamune™
21:05 EDT 8 Jul 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
LAWRENCEBURG, Ind., July 9, 2012 /PRNewswire/ -- PDS Biotechnology Corporation announced today that they have entered into an exclusive worldwide licensing agreement with Merck KGaA, Darmstadt, Germany, for use of PDS Biotechnology's novel Vers...
Other Sources for this Article
More From BioPortfolio on "PDS Biotechnology Corporation Signs Worldwide Licensing Agreement with Merck KGaA for Versamune™"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
